Fig. 1

Flow diagram demonstrating treatment group assignment. MF myelofibrosis, DIPSS dynamic international prognostic scoring system, Int Intermediate, AP accelerated phase, BP blast phase, JAKi JAK inhibitor therapy, HCT allogeneic hematopoietic cell transplantation.